MPI-0479605
Title | Journal |
---|---|
Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors. | Bioorganic & medicinal chemistry letters 20120701 |
Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1. | Molecular cancer therapeutics 20111201 |